Our services include various in vivo disease models, mode of action platforms, screening and biomarker analysis using all available methods. Combined in vitro, in vivo and ex vivo analysis enable complex study designs to maximize the data obtained.
|Biologics/NBEs(Abs, Peptides, Proteins)||Implants|
|New Chemical Entities/NCEs||Patches|
|Plant-based compounds||Slow release drug/device combination|
|Cell based therapies|